Total Payments
$18,012
2022 Payments
$186.71
Companies
4
Transactions
28
Medicare Patients
1,209
Medicare Billing
$161,087
Payment Breakdown by Category
Consulting$15,000 (83.3%)
Travel$1,962 (10.9%)
Food & Beverage$1,050 (5.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $15,000 | 3 | 83.3% |
| Travel and Lodging | $1,962 | 8 | 10.9% |
| Food and Beverage | $1,050 | 17 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $17,258 | 17 | $0 (2020) |
| United Therapeutics Corporation | $689.51 | 9 | $0 (2022) |
| Actelion Pharmaceuticals US, Inc. | $40.00 | 1 | $0 (2021) |
| Biohaven Pharmaceuticals, Inc. | $24.28 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $186.71 | 2 | United Therapeutics Corporation ($186.71) |
| 2021 | $187.16 | 4 | United Therapeutics Corporation ($122.88) |
| 2020 | $2,067 | 3 | Merck Sharp & Dohme Corporation ($2,000) |
| 2019 | $7,676 | 10 | Merck Sharp & Dohme Corporation ($7,471) |
| 2018 | $7,895 | 9 | Merck Sharp & Dohme Corporation ($7,787) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2022 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $65.42 | General |
| Category: PAH | ||||||
| 02/09/2022 | United Therapeutics Corporation | TYVASO (Drug), REMODULIN | Food and Beverage | In-kind items and services | $121.29 | General |
| Category: PAH | ||||||
| 12/01/2021 | Actelion Pharmaceuticals US, Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 10/29/2021 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $103.42 | General |
| 10/29/2021 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: PAH | ||||||
| 10/16/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: PRIMARY CARE | ||||||
| 03/05/2020 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PAH | ||||||
| 03/04/2020 | Merck Sharp & Dohme Corporation | MK-5475 (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/30/2020 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $47.47 | General |
| 10/10/2019 | Merck Sharp & Dohme Corporation | MK-5475 (Drug) | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/10/2019 | Merck Sharp & Dohme Corporation | MK-5475 (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/29/2019 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $80.27 | General |
| 09/23/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $65.00 | General |
| 09/23/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $56.00 | General |
| 09/23/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $54.99 | General |
| 09/23/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $34.91 | General |
| 09/22/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $358.88 | General |
| 09/22/2019 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $250.74 | General |
| 05/20/2019 | United Therapeutics Corporation | TYVASO (Drug), ORENITRAM | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PAH | ||||||
| 09/24/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Consulting Fee | Cash or cash equivalent | $6,500.00 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2018 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2018 | Merck Sharp & Dohme Corporation | — | Travel and Lodging | In-kind items and services | $57.88 | General |
| 06/18/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $47.18 | General |
| 06/18/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $39.99 | General |
| 06/18/2018 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $33.03 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 328 | 354 | $166,160 | $31,888 |
| 2022 | 6 | 274 | 351 | $179,285 | $36,182 |
| 2021 | 6 | 307 | 416 | $215,277 | $45,189 |
| 2020 | 6 | 300 | 422 | $221,354 | $47,828 |
Total Patients
1,209
Total Services
1,543
Medicare Billing
$161,087
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 103 | 105 | $62,895 | $12,020 | 19.1% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2023 | 181 | 190 | $53,686 | $10,459 | 19.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 29 | $25,549 | $5,189 | 20.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 30 | 30 | $24,030 | $4,219 | 17.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 23 | 60 | $52,104 | $11,134 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 65 | 67 | $39,381 | $7,850 | 19.9% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2022 | 121 | 126 | $36,038 | $7,111 | 19.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 34 | 34 | $25,584 | $4,600 | 18.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 51 | $21,009 | $4,466 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 13 | $5,169 | $1,021 | 19.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 24 | 71 | $63,088 | $13,426 | 21.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 84 | 97 | $47,280 | $10,736 | 22.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 32 | 74 | $31,360 | $6,615 | 21.1% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2021 | 119 | 125 | $36,274 | $6,422 | 17.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 23 | 24 | $19,800 | $4,160 | 21.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 25 | 25 | $17,475 | $3,830 | 21.9% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 32 | 111 | $98,711 | $22,305 | 22.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 93 | 115 | $51,504 | $10,845 | 21.1% |
| 94621 | Test for exercise-induced heart and lung stress | Facility | 2020 | 111 | 117 | $32,679 | $6,787 | 20.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 30 | 30 | $20,284 | $3,876 | 19.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 12 | 26 | $10,910 | $2,406 | 22.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 22 | 23 | $7,266 | $1,609 | 22.1% |
About Dr. David Systrom, MD
Dr. David Systrom, MD is a Internal Medicine healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003806282.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Systrom, MD has received a total of $18,012 in payments from pharmaceutical and medical device companies, with $186.71 received in 2022. These payments were reported across 28 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($15,000).
As a Medicare-enrolled provider, Systrom has provided services to 1,209 Medicare beneficiaries, totaling 1,543 services with total Medicare billing of $161,087. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Boston, MA
- Active Since 10/27/2005
- Last Updated 08/29/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1003806282
Products in Payments
- MK-5475 (Drug) $8,650
- KEYTRUDA (Biological) $6,650
- TYVASO (Drug) $458.35
- NURTEC ODT (Drug) $24.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Boston
Michael Mendelsohn, M.d, M.D
Internal Medicine — Payments: $4.6M
Internal Medicine $4.6M
David Schenkein, Md, MD
Internal Medicine — Payments: $4.0M
Internal Medicine $4.0M
Dr. John Fallon, M.d, M.D
Internal Medicine — Payments: $2.5M
Internal Medicine $2.5M
Dr. David Scadden, Md, MD
Internal Medicine — Payments: $2.2M
Internal Medicine $2.2M
Dr. James Januzzi, Md, MD
Internal Medicine — Payments: $1.8M
Internal Medicine $1.8M
Dr. Marilyn Pike, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M